Immune control of tuberculosis by IFN-gamma-inducible LRG-47
IFN-γ 诱导型 LRG-47 对结核病的免疫控制
基本信息
- 批准号:7470658
- 负责人:
- 金额:$ 31.53万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-07-01 至 2011-06-30
- 项目状态:已结题
- 来源:
- 关键词:AccountingAntigensBehaviorCause of DeathCell FractionationCellsClinicalCytokine ActivationDendritic CellsDetectionDiseaseDrug Delivery SystemsEventFamilyFamily memberGenesGenetic ScreeningGleanGrowthGuanosineGuanosine Triphosphate PhosphohydrolasesHIVHIV-1Host DefenseHost resistanceHumanImageImmuneImmune responseImmunityImmunocompetentImmunologistIndividualInfectionInterferon Type IILesionLifeLinkLocationMicroscopyMolecularMusMutationMycobacterium tuberculosisNOS2A geneNumbersOrganellesOutcomePathway interactionsPhagosomesPharmacotherapyPlaguePlayPopulationProteinsPurposeResolutionRoleRouteSurrogate MarkersT-LymphocyteThinkingTimeTuberculosisVaccine DesignVirulence Factorscytokinehuman AKAP13 proteinhuman NOS2A proteininsightkillingsmacrophagemammalian genomemembermolecular arraymouse modelnovelpandemic diseasepathogenprogesterone 11-hemisuccinate-(2-iodohistamine)programsprospectiveprotective effectresponsetraffickingvaccine efficacy
项目摘要
DESCRIPTION (provided by applicant): Natural mutations in humans and introduced mutations in mice have unequivocally demonstrated the importance of interferon-gamma (IFN-gamma) for the control of tuberculosis (TB). How this cytokine exerts its protective effects is thought to owe much to the broad transcriptional programs it activates within Mycobacterium tuberculosis (Mto)-infected macrophages and dendritic cells. Here as many as 1,300 genes may be engaged. Prominent within this group is a new family of 47kDa guanosine 5'-triphosphatases (p47 GTPases) that confers host resistance to a number of human pathogens. At least one member of this family - LRG-47 - appears essential for combating TB in experimental mouse models. Preliminary evidence suggests that LRG-47 operates at the level of the infected cell via a mechanism distinct from all known tuberculocidal pathways, linking cytokine activation with phagolysomal fusion, events that are required for bacterial killing and which may enable Mtb antigens to be cross-presented. It is the purpose of this proposal to build on these initial observations by pursuing the following aims: (1) Characterize the intracellular location and trafficking behavior of mouse and human LRG-47 within Mtb-infected cells. Here a combination of high-resolution imaging and cell fractionation will be used to identify the LRG-47-positive compartment(s) and its recruitment to the nascent Mtb phagosome. (2) Define the molecular determinants of LRG-47 function in response to Mtb. Relocation of LRG-47 to the Mtb phagosome and subsequent remodeling of this organelle is likely to enlist other host proteins. Isolating LRG-47-interacting partners, the functional domains involved and their consequences for immunity will be dissected with an array of molecular, cellular and structural approaches. (3) Uncover Mtb-encoded pathways that counter LRG-47 - dependent immunity. Genetic screens conducted to identify bacterial components interfering with LRG-47 should yield further insights into how this GTPase operates. It could also uncover prospective drug targets. Information gleaned from these approaches will provide a paradigm for other members of the p47 GTPase family that is rapidly emerging as one of the most powerful host defense repertoires in the mammalian genome.
描述(由申请人提供):人类的自然突变和小鼠的引入突变已明确证明了干扰素-γ(IFN-γ)对于控制结核病(TB)的重要性。这种细胞因子如何发挥其保护作用被认为很大程度上归功于它在结核分枝杆菌 (Mto) 感染的巨噬细胞和树突状细胞中激活的广泛转录程序。这里可能涉及多达 1,300 个基因。该组中最突出的是一个新的 47kDa 鸟苷 5'-三磷酸酶 (p47 GTPases) 家族,它赋予宿主对多种人类病原体的抵抗力。该家族的至少一个成员——LRG-47——似乎对于实验小鼠模型中对抗结核病至关重要。初步证据表明,LRG-47 在受感染细胞水平上发挥作用,其机制不同于所有已知的杀结核途径,将细胞因子激活与吞噬溶酶体融合联系起来,这是杀死细菌所需的事件,并且可能使 Mtb 抗原能够交叉呈递。本提案的目的是通过追求以下目标来建立这些初步观察结果:(1)表征小鼠和人类 LRG-47 在 Mtb 感染细胞内的细胞内位置和运输行为。在这里,高分辨率成像和细胞分级分离的组合将用于识别 LRG-47 阳性区室及其招募到新生 Mtb 吞噬体的情况。 (2) 定义 LRG-47 响应 Mtb 功能的分子决定因素。 LRG-47 重新定位到 Mtb 吞噬体以及随后对该细胞器的重塑可能会招募其他宿主蛋白。将通过一系列分子、细胞和结构方法来分离 LRG-47 相互作用伙伴、所涉及的功能域及其对免疫的影响。 (3) 发现对抗 LRG-47 依赖性免疫的 Mtb 编码途径。为鉴定干扰 LRG-47 的细菌成分而进行的遗传筛选应该可以进一步了解这种 GTP 酶的运作方式。它还可以发现潜在的药物靶点。从这些方法中收集的信息将为 p47 GTPase 家族的其他成员提供范例,该家族正迅速成为哺乳动物基因组中最强大的宿主防御库之一。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
John David MacMicking其他文献
John David MacMicking的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('John David MacMicking', 18)}}的其他基金
GBPs as new inflammsome regulators during mammalian host defense
GBP 作为哺乳动物宿主防御过程中新的炎症调节剂
- 批准号:
8929155 - 财政年份:2014
- 资助金额:
$ 31.53万 - 项目类别:
GBPs as new inflammsome regulators during mammalian host defense
GBP 作为哺乳动物宿主防御过程中新的炎症调节剂
- 批准号:
9124701 - 财政年份:2014
- 资助金额:
$ 31.53万 - 项目类别:
GBPs as new inflammsome regulators during mammalian host defense
GBP 作为哺乳动物宿主防御过程中新的炎症调节剂
- 批准号:
8816302 - 财政年份:2014
- 资助金额:
$ 31.53万 - 项目类别:
GBPs as new inflammasome regulators during mammalian host defense
GBP 作为哺乳动物宿主防御过程中新的炎症小体调节剂
- 批准号:
10535452 - 财政年份:2014
- 资助金额:
$ 31.53万 - 项目类别:
GBPs as new inflammasome regulators during mammalian host defense
GBP 作为哺乳动物宿主防御过程中新的炎症小体调节剂
- 批准号:
10307127 - 财政年份:2014
- 资助金额:
$ 31.53万 - 项目类别:
GBPs as new inflammasome regulators during mammalian host defense
GBP 作为哺乳动物宿主防御过程中新的炎症小体调节剂
- 批准号:
10083168 - 财政年份:2014
- 资助金额:
$ 31.53万 - 项目类别:
GBPs as new inflammsome regulators during mammalian host defense
GBP 作为哺乳动物宿主防御过程中新的炎症调节剂
- 批准号:
9330052 - 财政年份:2014
- 资助金额:
$ 31.53万 - 项目类别:
A Novel CDN Sensor-Adaptor System for Host Defense Against Infection
用于主机防御感染的新型 CDN 传感器适配器系统
- 批准号:
10165463 - 财政年份:2006
- 资助金额:
$ 31.53万 - 项目类别:
Immune control of tuberculosis by IFN-gamma-inducible LRG-47
IFN-γ 诱导型 LRG-47 对结核病的免疫控制
- 批准号:
7250105 - 财政年份:2006
- 资助金额:
$ 31.53万 - 项目类别:
Immune control of tuberculosis by IFN-gamma-inducible LRG-47
IFN-γ 诱导型 LRG-47 对结核病的免疫控制
- 批准号:
7644539 - 财政年份:2006
- 资助金额:
$ 31.53万 - 项目类别:
相似国自然基金
嵌合抗原受体巨噬细胞(CAR-M)微马达的制备及其血管蜂窝网络磁驱行为机理与控制方法研究
- 批准号:52375565
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
金属硫蛋白MT1介导癌-睾丸抗原CT23影响肝癌恶性生物学行为的研究
- 批准号:81760424
- 批准年份:2017
- 资助金额:34.0 万元
- 项目类别:地区科学基金项目
甲状腺乳头状癌的免疫原性及其对生物学行为的影响研究
- 批准号:81672641
- 批准年份:2016
- 资助金额:57.0 万元
- 项目类别:面上项目
癌-睾丸抗原OY-TES-1 对脑肿瘤恶性生物学行为的影响及抗体血清学分析
- 批准号:81360374
- 批准年份:2013
- 资助金额:40.0 万元
- 项目类别:地区科学基金项目
肿瘤相关抗原CHP2对卵巢癌生物学行为的影响及其机制探讨
- 批准号:30571953
- 批准年份:2005
- 资助金额:25.0 万元
- 项目类别:面上项目
相似海外基金
Developing a regionally representative risk assessment tool to identify men at highest risk of HIV acquisition in sub-Saharan Africa
开发具有区域代表性的风险评估工具,以确定撒哈拉以南非洲地区感染艾滋病毒风险最高的男性
- 批准号:
10762645 - 财政年份:2023
- 资助金额:
$ 31.53万 - 项目类别:
Pro-Oncogenic Role of a Mitochondrial Lipid Kinase in CLL
线粒体脂质激酶在 CLL 中的促癌作用
- 批准号:
10651077 - 财政年份:2023
- 资助金额:
$ 31.53万 - 项目类别:
Mechanisms and manipulation of force dependent behavior in T cell biology
T 细胞生物学中力依赖性行为的机制和操纵
- 批准号:
10681766 - 财政年份:2023
- 资助金额:
$ 31.53万 - 项目类别:
Study Pro-Oncogenic Role of BCL6 in CLL Tumorigenesis
研究 BCL6 在 CLL 肿瘤发生中的促癌作用
- 批准号:
10512700 - 财政年份:2022
- 资助金额:
$ 31.53万 - 项目类别:
Study Pro-Oncogenic Role of BCL6 in CLL Tumorigenesis
研究 BCL6 在 CLL 肿瘤发生中的促癌作用
- 批准号:
10661814 - 财政年份:2022
- 资助金额:
$ 31.53万 - 项目类别: